Modular Medical Statistics
Total Valuation
Modular Medical has a market cap or net worth of $28.20 million. The enterprise value is $24.56 million.
| Market Cap | 28.20M |
| Enterprise Value | 24.56M |
Important Dates
The last earnings date was Friday, August 14, 2026, after market close.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Modular Medical has 8.15 million shares outstanding. The number of shares has increased by 127.74% in one year.
| Current Share Class | 8.15M |
| Shares Outstanding | 8.15M |
| Shares Change (YoY) | +127.74% |
| Shares Change (QoQ) | +66.29% |
| Owned by Insiders (%) | 1.56% |
| Owned by Institutions (%) | 17.34% |
| Float | 7.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.79 |
| P/TBV Ratio | 2.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.25, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.25 |
| Quick Ratio | 2.79 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -247.94% and return on invested capital (ROIC) is -144.57%.
| Return on Equity (ROE) | -247.94% |
| Return on Assets (ROA) | -129.12% |
| Return on Invested Capital (ROIC) | -144.57% |
| Return on Capital Employed (ROCE) | -253.57% |
| Weighted Average Cost of Capital (WACC) | 5.10% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$549,529 |
| Employee Count | 51 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Modular Medical has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.44% in the last 52 weeks. The beta is 0.16, so Modular Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | -84.44% |
| 50-Day Moving Average | 3.31 |
| 200-Day Moving Average | 7.49 |
| Relative Strength Index (RSI) | 56.74 |
| Average Volume (20 Days) | 464,273 |
Short Selling Information
The latest short interest is 462,375, so 5.67% of the outstanding shares have been sold short.
| Short Interest | 462,375 |
| Short Previous Month | 188,517 |
| Short % of Shares Out | 5.67% |
| Short % of Float | 6.47% |
| Short Ratio (days to cover) | 1.65 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -27.29M |
| Pretax Income | -28.02M |
| Net Income | -28.03M |
| EBITDA | -25.53M |
| EBIT | -27.29M |
| Earnings Per Share (EPS) | -$8.77 |
Balance Sheet
The company has $3.92 million in cash and $278,000 in debt, with a net cash position of $3.64 million or $0.45 per share.
| Cash & Cash Equivalents | 3.92M |
| Total Debt | 278,000 |
| Net Cash | 3.64M |
| Net Cash Per Share | $0.45 |
| Equity (Book Value) | 10.76M |
| Book Value Per Share | 1.93 |
| Working Capital | 3.36M |
Cash Flow
In the last 12 months, operating cash flow was -$24.35 million and capital expenditures -$3.69 million, giving a free cash flow of -$28.04 million.
| Operating Cash Flow | -24.35M |
| Capital Expenditures | -3.69M |
| Depreciation & Amortization | 1.76M |
| Net Borrowing | n/a |
| Free Cash Flow | -28.04M |
| FCF Per Share | -$3.44 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Modular Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -127.74% |
| Shareholder Yield | -127.74% |
| Earnings Yield | -99.38% |
| FCF Yield | -99.42% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 31, 2026. It was a reverse split with a ratio of 1:30.
| Last Split Date | Mar 31, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |